Depression, Diabetic Complications and Disability Among Persons With Comorbid Schizophrenia and Type 2 Diabetes
Background People with schizophrenia are at increased risk for type 2 diabetes, its complications, depression, and disability. However, little is known about the interrelationships of these 3 factors in adults with schizophrenia and type 2 diabetes. Objective We sought to assess the number of diabet...
Gespeichert in:
Veröffentlicht in: | Psychosomatics (Washington, D.C.) D.C.), 2014-07, Vol.55 (4), p.343-351 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 351 |
---|---|
container_issue | 4 |
container_start_page | 343 |
container_title | Psychosomatics (Washington, D.C.) |
container_volume | 55 |
creator | Lee, Aaron A., M.S McKibbin, Christine L., Ph.D Bourassa, Katelynn A., B.A Wykes, Thomas L., M.S Kitchen Andren, Katherine A., M.S |
description | Background People with schizophrenia are at increased risk for type 2 diabetes, its complications, depression, and disability. However, little is known about the interrelationships of these 3 factors in adults with schizophrenia and type 2 diabetes. Objective We sought to assess the number of diabetic complications and depressive symptom severity as predictors of disability and evaluate depressive symptom severity as a mediator of the relationship between diabetic complications and disability in a sample of 62 adults with schizophrenia and type 2 diabetes. Methods Two- and 3-step sequential regression models were used to evaluate the relationship of depression and number of diabetic complications with disability. Path analysis with bootstrapping was used to evaluate depressive symptom severity as a mediator of the relationship between complications and disability. Results Diabetic complications significantly predicted disability scores when controlling for age, gender, socioeconomic status, hemoglobin A1C, positive symptom severity, and negative symptom severity. The addition of depression severity scores resulted in a significant increase in explained variance in disability scores. In the final model, only depression severity scores were significantly associated with disability scores. The full model accounted for 56.2% of the variance in disability scores. Path analysis revealed a significant indirect association of diabetic complications to disability through depression severity scores while controlling for all covariates. The association between complications and disability was nonsignificant when depressive symptom severity was included in the model. Conclusions Depressive symptoms may present an important and tractable target for interventions aimed at reducing disability in people with schizophrenia and type 2 diabetes. |
doi_str_mv | 10.1016/j.psym.2013.12.015 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10066802</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0033318213002478</els_id><sourcerecordid>1543678996</sourcerecordid><originalsourceid>FETCH-LOGICAL-c558t-48356fc9e8b73fc8618c8f9a2e2e04b5144dc50691044ae05d738456c3013d6f3</originalsourceid><addsrcrecordid>eNpVkk9v1DAQxSMEokvhC3BAuSBxIGFsx473Aqq25Y9UCaQWcbQcZ9L1ktipna2UfnocdilwsuT5zZvRe5NlLwmUBIh4tyvHOA8lBcJKQksg_FG2IrziRU1BPM5WAIwVjEh6kj2LcQcAnHDxNDuhVc0JIXSV-XMcA8ZovXubn1vd4GRNvvHD2Fujp_Qdc-3aVIq6sb2d5vxs8O4m_4YhLsUfdtouvA-NbfMrs7X3ftwGdFb_bryeR8zpURrj8-xJp_uIL47vafb948X15nNx-fXTl83ZZWE4l1NRScZFZ9Yom5p1RgoijezWmiJFqBpOqqo1HMSaQFVpBN7WTFZcGJbMaEXHTrMPB91x3wzYGnRT0L0agx10mJXXVv1fcXarbvydIgBCSKBJ4c1RIfjbPcZJDTYa7Hvt0O-jSkYzUcv1WiSUHlATfIwBu4c5BNQSldqpJSq1RKUIVSmq1PTq3w0fWv5kk4DXR0BHo_suaGds_MslU6DiC_f-wGHy885iUKa3LqXX_8QZ487vg0tWK6JimqyulqtYjoIwgDRMsl8b-rNw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1543678996</pqid></control><display><type>article</type><title>Depression, Diabetic Complications and Disability Among Persons With Comorbid Schizophrenia and Type 2 Diabetes</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lee, Aaron A., M.S ; McKibbin, Christine L., Ph.D ; Bourassa, Katelynn A., B.A ; Wykes, Thomas L., M.S ; Kitchen Andren, Katherine A., M.S</creator><creatorcontrib>Lee, Aaron A., M.S ; McKibbin, Christine L., Ph.D ; Bourassa, Katelynn A., B.A ; Wykes, Thomas L., M.S ; Kitchen Andren, Katherine A., M.S</creatorcontrib><description>Background People with schizophrenia are at increased risk for type 2 diabetes, its complications, depression, and disability. However, little is known about the interrelationships of these 3 factors in adults with schizophrenia and type 2 diabetes. Objective We sought to assess the number of diabetic complications and depressive symptom severity as predictors of disability and evaluate depressive symptom severity as a mediator of the relationship between diabetic complications and disability in a sample of 62 adults with schizophrenia and type 2 diabetes. Methods Two- and 3-step sequential regression models were used to evaluate the relationship of depression and number of diabetic complications with disability. Path analysis with bootstrapping was used to evaluate depressive symptom severity as a mediator of the relationship between complications and disability. Results Diabetic complications significantly predicted disability scores when controlling for age, gender, socioeconomic status, hemoglobin A1C, positive symptom severity, and negative symptom severity. The addition of depression severity scores resulted in a significant increase in explained variance in disability scores. In the final model, only depression severity scores were significantly associated with disability scores. The full model accounted for 56.2% of the variance in disability scores. Path analysis revealed a significant indirect association of diabetic complications to disability through depression severity scores while controlling for all covariates. The association between complications and disability was nonsignificant when depressive symptom severity was included in the model. Conclusions Depressive symptoms may present an important and tractable target for interventions aimed at reducing disability in people with schizophrenia and type 2 diabetes.</description><identifier>ISSN: 0033-3182</identifier><identifier>EISSN: 1545-7206</identifier><identifier>DOI: 10.1016/j.psym.2013.12.015</identifier><identifier>PMID: 24751112</identifier><language>eng</language><publisher>Arlington, VA: American Psychiatric Publishing</publisher><subject>Adult and adolescent clinical studies ; Biological and medical sciences ; Depression ; Depression - etiology ; Diabetes Complications - etiology ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - psychology ; Diabetes. Impaired glucose tolerance ; Disabled Persons - psychology ; Disabled Persons - statistics & numerical data ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Female ; Humans ; Internal Medicine ; Male ; Medical sciences ; Middle Aged ; Miscellaneous ; Mood disorders ; Psychiatric Status Rating Scales ; Psychiatry ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychoses ; Risk Factors ; Schizophrenia ; Schizophrenia - complications</subject><ispartof>Psychosomatics (Washington, D.C.), 2014-07, Vol.55 (4), p.343-351</ispartof><rights>Academy of Psychosomatic Medicine</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2014 Academy of Psychosomatic Medicine. Published by Elsevier Inc. All rights reserved.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c558t-48356fc9e8b73fc8618c8f9a2e2e04b5144dc50691044ae05d738456c3013d6f3</citedby><cites>FETCH-LOGICAL-c558t-48356fc9e8b73fc8618c8f9a2e2e04b5144dc50691044ae05d738456c3013d6f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28610452$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24751112$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Aaron A., M.S</creatorcontrib><creatorcontrib>McKibbin, Christine L., Ph.D</creatorcontrib><creatorcontrib>Bourassa, Katelynn A., B.A</creatorcontrib><creatorcontrib>Wykes, Thomas L., M.S</creatorcontrib><creatorcontrib>Kitchen Andren, Katherine A., M.S</creatorcontrib><title>Depression, Diabetic Complications and Disability Among Persons With Comorbid Schizophrenia and Type 2 Diabetes</title><title>Psychosomatics (Washington, D.C.)</title><addtitle>Psychosomatics</addtitle><description>Background People with schizophrenia are at increased risk for type 2 diabetes, its complications, depression, and disability. However, little is known about the interrelationships of these 3 factors in adults with schizophrenia and type 2 diabetes. Objective We sought to assess the number of diabetic complications and depressive symptom severity as predictors of disability and evaluate depressive symptom severity as a mediator of the relationship between diabetic complications and disability in a sample of 62 adults with schizophrenia and type 2 diabetes. Methods Two- and 3-step sequential regression models were used to evaluate the relationship of depression and number of diabetic complications with disability. Path analysis with bootstrapping was used to evaluate depressive symptom severity as a mediator of the relationship between complications and disability. Results Diabetic complications significantly predicted disability scores when controlling for age, gender, socioeconomic status, hemoglobin A1C, positive symptom severity, and negative symptom severity. The addition of depression severity scores resulted in a significant increase in explained variance in disability scores. In the final model, only depression severity scores were significantly associated with disability scores. The full model accounted for 56.2% of the variance in disability scores. Path analysis revealed a significant indirect association of diabetic complications to disability through depression severity scores while controlling for all covariates. The association between complications and disability was nonsignificant when depressive symptom severity was included in the model. Conclusions Depressive symptoms may present an important and tractable target for interventions aimed at reducing disability in people with schizophrenia and type 2 diabetes.</description><subject>Adult and adolescent clinical studies</subject><subject>Biological and medical sciences</subject><subject>Depression</subject><subject>Depression - etiology</subject><subject>Diabetes Complications - etiology</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - psychology</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Disabled Persons - psychology</subject><subject>Disabled Persons - statistics & numerical data</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Female</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Miscellaneous</subject><subject>Mood disorders</subject><subject>Psychiatric Status Rating Scales</subject><subject>Psychiatry</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychoses</subject><subject>Risk Factors</subject><subject>Schizophrenia</subject><subject>Schizophrenia - complications</subject><issn>0033-3182</issn><issn>1545-7206</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkk9v1DAQxSMEokvhC3BAuSBxIGFsx473Aqq25Y9UCaQWcbQcZ9L1ktipna2UfnocdilwsuT5zZvRe5NlLwmUBIh4tyvHOA8lBcJKQksg_FG2IrziRU1BPM5WAIwVjEh6kj2LcQcAnHDxNDuhVc0JIXSV-XMcA8ZovXubn1vd4GRNvvHD2Fujp_Qdc-3aVIq6sb2d5vxs8O4m_4YhLsUfdtouvA-NbfMrs7X3ftwGdFb_bryeR8zpURrj8-xJp_uIL47vafb948X15nNx-fXTl83ZZWE4l1NRScZFZ9Yom5p1RgoijezWmiJFqBpOqqo1HMSaQFVpBN7WTFZcGJbMaEXHTrMPB91x3wzYGnRT0L0agx10mJXXVv1fcXarbvydIgBCSKBJ4c1RIfjbPcZJDTYa7Hvt0O-jSkYzUcv1WiSUHlATfIwBu4c5BNQSldqpJSq1RKUIVSmq1PTq3w0fWv5kk4DXR0BHo_suaGds_MslU6DiC_f-wGHy885iUKa3LqXX_8QZ487vg0tWK6JimqyulqtYjoIwgDRMsl8b-rNw</recordid><startdate>20140701</startdate><enddate>20140701</enddate><creator>Lee, Aaron A., M.S</creator><creator>McKibbin, Christine L., Ph.D</creator><creator>Bourassa, Katelynn A., B.A</creator><creator>Wykes, Thomas L., M.S</creator><creator>Kitchen Andren, Katherine A., M.S</creator><general>American Psychiatric Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140701</creationdate><title>Depression, Diabetic Complications and Disability Among Persons With Comorbid Schizophrenia and Type 2 Diabetes</title><author>Lee, Aaron A., M.S ; McKibbin, Christine L., Ph.D ; Bourassa, Katelynn A., B.A ; Wykes, Thomas L., M.S ; Kitchen Andren, Katherine A., M.S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c558t-48356fc9e8b73fc8618c8f9a2e2e04b5144dc50691044ae05d738456c3013d6f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult and adolescent clinical studies</topic><topic>Biological and medical sciences</topic><topic>Depression</topic><topic>Depression - etiology</topic><topic>Diabetes Complications - etiology</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - psychology</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Disabled Persons - psychology</topic><topic>Disabled Persons - statistics & numerical data</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Female</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Miscellaneous</topic><topic>Mood disorders</topic><topic>Psychiatric Status Rating Scales</topic><topic>Psychiatry</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychoses</topic><topic>Risk Factors</topic><topic>Schizophrenia</topic><topic>Schizophrenia - complications</topic><toplevel>online_resources</toplevel><creatorcontrib>Lee, Aaron A., M.S</creatorcontrib><creatorcontrib>McKibbin, Christine L., Ph.D</creatorcontrib><creatorcontrib>Bourassa, Katelynn A., B.A</creatorcontrib><creatorcontrib>Wykes, Thomas L., M.S</creatorcontrib><creatorcontrib>Kitchen Andren, Katherine A., M.S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Psychosomatics (Washington, D.C.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Aaron A., M.S</au><au>McKibbin, Christine L., Ph.D</au><au>Bourassa, Katelynn A., B.A</au><au>Wykes, Thomas L., M.S</au><au>Kitchen Andren, Katherine A., M.S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Depression, Diabetic Complications and Disability Among Persons With Comorbid Schizophrenia and Type 2 Diabetes</atitle><jtitle>Psychosomatics (Washington, D.C.)</jtitle><addtitle>Psychosomatics</addtitle><date>2014-07-01</date><risdate>2014</risdate><volume>55</volume><issue>4</issue><spage>343</spage><epage>351</epage><pages>343-351</pages><issn>0033-3182</issn><eissn>1545-7206</eissn><abstract>Background People with schizophrenia are at increased risk for type 2 diabetes, its complications, depression, and disability. However, little is known about the interrelationships of these 3 factors in adults with schizophrenia and type 2 diabetes. Objective We sought to assess the number of diabetic complications and depressive symptom severity as predictors of disability and evaluate depressive symptom severity as a mediator of the relationship between diabetic complications and disability in a sample of 62 adults with schizophrenia and type 2 diabetes. Methods Two- and 3-step sequential regression models were used to evaluate the relationship of depression and number of diabetic complications with disability. Path analysis with bootstrapping was used to evaluate depressive symptom severity as a mediator of the relationship between complications and disability. Results Diabetic complications significantly predicted disability scores when controlling for age, gender, socioeconomic status, hemoglobin A1C, positive symptom severity, and negative symptom severity. The addition of depression severity scores resulted in a significant increase in explained variance in disability scores. In the final model, only depression severity scores were significantly associated with disability scores. The full model accounted for 56.2% of the variance in disability scores. Path analysis revealed a significant indirect association of diabetic complications to disability through depression severity scores while controlling for all covariates. The association between complications and disability was nonsignificant when depressive symptom severity was included in the model. Conclusions Depressive symptoms may present an important and tractable target for interventions aimed at reducing disability in people with schizophrenia and type 2 diabetes.</abstract><cop>Arlington, VA</cop><pub>American Psychiatric Publishing</pub><pmid>24751112</pmid><doi>10.1016/j.psym.2013.12.015</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0033-3182 |
ispartof | Psychosomatics (Washington, D.C.), 2014-07, Vol.55 (4), p.343-351 |
issn | 0033-3182 1545-7206 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10066802 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adult and adolescent clinical studies Biological and medical sciences Depression Depression - etiology Diabetes Complications - etiology Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - psychology Diabetes. Impaired glucose tolerance Disabled Persons - psychology Disabled Persons - statistics & numerical data Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Female Humans Internal Medicine Male Medical sciences Middle Aged Miscellaneous Mood disorders Psychiatric Status Rating Scales Psychiatry Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychoses Risk Factors Schizophrenia Schizophrenia - complications |
title | Depression, Diabetic Complications and Disability Among Persons With Comorbid Schizophrenia and Type 2 Diabetes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T12%3A02%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Depression,%20Diabetic%20Complications%20and%20Disability%20Among%20Persons%20With%20Comorbid%20Schizophrenia%20and%20Type%202%20Diabetes&rft.jtitle=Psychosomatics%20(Washington,%20D.C.)&rft.au=Lee,%20Aaron%20A.,%20M.S&rft.date=2014-07-01&rft.volume=55&rft.issue=4&rft.spage=343&rft.epage=351&rft.pages=343-351&rft.issn=0033-3182&rft.eissn=1545-7206&rft_id=info:doi/10.1016/j.psym.2013.12.015&rft_dat=%3Cproquest_pubme%3E1543678996%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1543678996&rft_id=info:pmid/24751112&rft_els_id=1_s2_0_S0033318213002478&rfr_iscdi=true |